December 6 – 7, 2022
Troutman Pepper is proud to sponsor the American Conference Institute's (ACI) 27th Annual Conference on Drug & Medical Device Litigation taking place on December 6-7, 2022, at the New York Marriott Marquis, New York, NY.
ACI's Drug and Medical Device Litigation conference has brought together the greatest minds and leaders in the pharmaceutical and medical device industry for the last two decades. Designed for masters-level strategy sharing and bringing together hundreds of industry leaders each year from both in-house, private practice, and government, this is the only forum at which to gain essential winning life sciences product liability litigation strategies.
Sean P. Fahey, partner and chair of Troutman Pepper's Health Sciences Litigation Practice, will be speaking on Tuesday, December 6 at 11:00 a.m., for the panel discussion, "Overcoming the Trials and Tribulations of Plaintiff Census Forms and Registries: What's Working, What's Not, and How the Newly Proposed MDL Rule Changes May Improve the System."
The session will cover:
-
How has the use of plaintiff census forms and registries been playing out in recent prominent MDLs?
-
How is the data in these forms impacting judicial decisions and future proceedings?
-
Assessing the pros and cons of these census registries: are they actually working as intended?
-
Addressing collateral issues: how are these census registries impacting the tolling of Statute of Limitations?
-
How can defendants effectively move cases off a census registry that don't belong?
-
Examining recent proposed MDL rule changes that aim to improve early vetting of claims
-
What will the new rules require with regard to early proofs of product use and injury, and how might this impact the efficiency of plaintiff registries?